The no-reflow phenomenon associated with percutaneous coronary intervention: Its mechanisms and treatment

Cardiovascular Intervention and Therapeutics

Volumn 26, Issue 1, 2011, Pages 2-11

  Ito, Hiroshi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Cardiac function; Coronary intervention; Microcirculation; Myocardial infarction; Reperfusion

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ADENOSINE; CARIPORIDE; CLOPIDOGREL; CREATINE KINASE MB; ENIPORIDE; ERYTHROPOIETIN; NICARDIPINE; NICORANDIL; NITROPRUSSIDE SODIUM; PAPAVERINE; VERAPAMIL;

ACUTE CORONARY SYNDROME; ANGIOCARDIOGRAPHY; BLOOD CLOT LYSIS; CARDIOVASCULAR MAGNETIC RESONANCE; CONTRAST ECHOCARDIOGRAPHY; DRUG MEGADOSE; ELECTROCARDIOGRAPHY; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HUMAN; INTRACORONARY INFUSION; ISCHEMIC PRECONDITIONING; LEUKOCYTE ACTIVATION; MULTICENTER STUDY (TOPIC); NO REFLOW PHENOMENON; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; THROMBECTOMY;

EID: 84863000722     PISSN: 18684300     EISSN: 18684297     Source Type: Journal    
DOI: 10.1007/s12928-010-0034-z     Document Type: Review

References (59)

1. Ito H, Tomooka T, Sakai N, Yu H, Higashino Y, Fujii K, et al. Lack of myocardial perfusion immediately after successful thrombolysis: a predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation. 1992; 85: 1699-705.
2. Kaul S, Ito H. Microvasculature in acute myocardial ischemia: part I. Evolving concepts in pathophysiology, diagnosis, and treatment. Circulation. 2004; 109: 310-5.
3. Ito H. No-reflow phenomenon and prognosis in patients with acute myocardial infarction. Nat Clin Pract Cardiovasc Med. 2006; 3: 499-506.
4. Kloner RA, Jennings RB. The 'no reflow' phenomenon after temporary occlusion in the dog. J Clin Invest. 1974; 54: 1491-508.
5. Bhatt DL, Topol EJ. Does creatinine kinase-MB elevation after percutaneous coronary intervention predict outcomes in 2005? Periprocedural cardiac enzyme elevation predicts adverse outcomes. Circulation. 2005; 112: 906-15.
6. Henriques JP, Zijlstra F, Ottervanger JP, de Boer MJ, van 't Hof AW, Hoorntje JC, et al. Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction. Eur Heart J. 2002; 23: 1112-7.
7. Kloner RA, Rude RE, Carlson N, Maroko PR, DeBoer LWV, Braunwald E. Ultrastructural evidence of microvascular damage and myocardial cell injury after coronary artery occlusion: which comes first? Circulation. 1980; 62: 945-52.
8. Ambrosio G, Weisman HF, Mannisi JA, Becker LC. Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow. Circulation. 1989; 80: 1846-61.
9. Califf RM, Abdelmeguid AE, Kuntz RE, Popma JJ, Davidson CJ, Cohen EA, et al. Myonecrosis after revascularization procedures. J Am Coll Cardiol. 1998; 31: 241-51.
10. Klein LW, Kramer BL, Howard E, Lesch M. Incidence and clinical significance of transient creatine kinase elevations and the diagnosis of non-Q wave myocardial infarction associated with coronary angioplasty. J Am Coll Cardiol. 1991; 17: 621-6.
11. Oh JK, Shub C, Ilstrup DM, Reeder GS. Creatine kinase release after successful percutaneous transluminal coronary angioplasty. Am Heart J. 1985; 109: 1225-31.
12. Topol EJ, Yadav JS. Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation. 2000; 101: 570-80.
13. Tanaka A, Kawarabayashi T, Nishibori Y, Sano T, Nishida Y, Fukuda D, et al. No-reflow phenomenon and lesion morphology in patients with acute myocardial infarction. Circulation. 2002; 105: 2148-52.
14. Rogers C, Huynh R, Seifert PA, Chevalier B, Schofer J, Edelman ER, et al. Embolic protection with filtering or occlusion balloons during saphenous vein graft stenting retrieves identical volumes and sizes of particulate debris. Circulation. 2004; 109: 1735-40.
15. Quan VH, Huynh R, Seifert PA, Kuchela A, Chen WH, Sutsch G, et al. Morphometric analysis of particulate debris extracted by four different embolic protection devices from coronary arteries, aortocoronary saphenous vein conduits, and carotid arteries. Am J Cardiol. 2005; 95: 1415-9.
16. Bailey SR. Drug-eluting stents have made brachytherapy obsolete. Curr Opin Cardiol. 2004; 19: 598-600.
17. Yamamoto K, Ito H, Iwakura K, Kawano S, Ikushima M, Masuyama T, et al. Two different coronary blood flow velocity patterns in thrombolysis in myocardial infarction grade 2 in acute myocardial infarction. J Am Coll Cardiol. 2002; 40: 1755-60.
18. Villanueva FS, Glasheen WP, Sklenar J, Kaul S. Characterization of spatial patterns of flow within the reperfused myocardium by myocardial contrast echocardiography. Implication in determining extent of myocardial salvage. Circulation. 1993; 88: 596-606.
19. Yano A, Ito H, Iwakura K, Kimura R, Tanaka K, Okamura A, et al. Myocardial contrast echocardiography with a new calibration method can estimate myocardial viability in patients with myocardial infarction. J Am Coll Cardiol. 2004; 43: 1799-806.
20. Ito H, Okamura A, Iwakura K, Masuyama T, Hori M, Takiuchi S, et al. Myocardial perfusion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction. Circulation. 1996; 9: 1993-9.
21. Akasaka T, Yoshida K, Kawamoto T, Kaji S, Ueda Y, Yamamuro A, et al. Relation of phasic coronary flow velocity characteristics with TIMI perfusion grade and myocardial recovery after primary percutaneous transluminal coronary angioplasty and rescue stenting. Circulation. 2000; 101: 2361-7.
22. Cannon CP. Importance of TIMI 3 flow. Circulation. 2001; 104: 624-6.
23. Iwakura K, Ito H, Takiuchi S, Taniyama Y, Nakatsuchi Y, Negoro S, et al. Alternation in the coronary blood flow velocity pattern in patients with no reflow and reperfused acute myocardial infarction. Circulation. 1996; 94: 1269-75.
24. Iwakura K, Ito H, Kawano S, Okamura A, Tanaka k, Nishida Y, et al. Assessing myocardial perfusion with the transthoracic Doppler technique in patients with reperfused anterior myocardial infarction: comparison with angiographic, enzymatic and electrocardiographic indices. Eur Heart J. 2004; 25: 1526-33.
25. Gibson CM, Cannon CP, Murphy SA, Ryan KA, Mesley R, Marble SJ, et al. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation. 2000; 101: 125-30.
26. Wu KC, Zerhouni EA, Judd RM, Lugo-Olivieri CH, Barouch LA, Schulman SP, et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation. 1998; 97: 765-72.
27. Matetzky S, Novikov M, Gruberg L, Freimark D, Feinberg M, Elian D, et al. The significance of persistent ST elevation versus early resolution of ST segment elevation after primary PTCA. J Am Coll Cardiol. 1999; 34: 1932-8.
28. Ito H, Maruyama A, Iwakura K, Takiuchi S, Masuyama T, Hori M, et al. Clinical implications of the "no reflow" phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation. 1996; 93: 223-8.
29. Dwivedi G, Janardhanan R, Hayat SA, Swinburn JM, Senior R. Prognostic value of myocardial viability detected by myocardial contrast echocardiography early after acute myocardial infarction. J Am Coll Cardiol. 2007; 50: 327-34.
30. Galiuto L, Garramone B, Scarà A, Rebuzzi AG, Crea F, Torre GL, on behalf of the AMICI Investigators, et al. The extent of microvascular damage during myocardial contrast echocardiography is superior to other known indexes of post-infarct reperfusion in predicting left ventricular remodeling. Results of the multicenter AMICI study. J Am Coll Cardiol. 2008; 51: 552-9.
31. De Luca G, Dudek D, Sardella G, Marino P, Chevalier B, Zijlstra F. Adjunctive manual thrombectomy improves myocardial perfusion and mortality in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized trials. Eur Heart J. 2008; 29: 3002-10.
32. Mongeon FP, Bélisle P, Joseph L, Eisenberg MJ, Rinfret S. Adjunctive thrombectomy for acute myocardial infarction: a Bayesian meta-analysis. Circ Cardiovasc Interv. 2010; 3: 6-16.
33. Bavry AA, Kumbhani DJ, Bhatt DL. Role of adjunctive thrombectomy and embolic protection devices in acute myocardial infarction: a comprehensive meta-analysis of randomized trials. Eur Heart J. 2008; 29: 2989-3001.
34. Nakamura T, Kubo N, Seki Y, Ikeda N, Ishida T, Funayama H, et al. Effects of a distal protection device during primary stenting in patients with acute anterior myocardial infarction. Circ J. 2004; 68: 763-8.
35. Li SS, Lam CW, So YC, Wong CH, Yiu SF, Ho D, et al. The use of a distal occlusion balloon protection device in acute coronary syndrome. Int J Cardiol. 2003; 92: 281-4.
36. Yip HK, Wu CJ, Chang HW, Fang CY, Yang CH, Chen SM, et al. Effect of the PercuSurge GuardWire device on the integrity of microvasculature and clinical outcomes during primary transradial coronary intervention in acute myocardial infarction. Am J Cardiol. 2003; 92: 1331-5.
37. Huang Z, Katoh O, Nakamura S, Negoro S, Kobayashi T, Tanigawa J. Evaluation of the PercuSurge Guardwire Plus Temporary Occlusion and Aspiration System during primary angioplasty in acute myocardial infarction. Catheter Cardiovasc Interv. 2003; 60: 443-51.
38. Orrego PS, Delgado A, Piccalo G, Salvadè P, Bonacina E, Klugmann S. Distal protection in native coronary arteries during primary angioplasty in acute myocardial infarction: single-center experience. Catheter Cardiovasc Interv. 2003; 60: 152-8.
39. Stone GW, Webb J, Cox DA, Brodie BR, Qureshi M, Kalynych A, et al. Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial. JAMA. 2005; 293: 1063-72.
40. Gick M, Jander N, Bestehorn HP, Kienzle RP, Ferenc M, Werner K, et al. Randomized evaluation of the effects of filter-based distal protection on myocardial perfusion and infarct size after primary percutaneous catheter intervention in myocardial infarction with and without ST-segment elevation. Circulation. 2005; 112: 1462-9.
41. Okamura A, Ito H, Iwakura K, Kawano S, Inoue K, Maekawa Y, et al. Detection of embolic particles with the Doppler guide wire during coronary intervention in patients with acute myocardial infarction. Efficacy of distal protection device. J Am Coll Cardiol. 2005; 45: 212-5.
42. Okamura A, Ito H, Iwakura K, Kurotobi T, Koyama Y, Date M, et al. Clinical implications of distal embolization during coronary interventional procedures in patients with acute myocardial infarction: quantitative study with Doppler guidewire. J Am Coll Cardiol Cardiovasc Interv. 2008; 1: 268-76.
43. Mizote I, Ueda Y, Ohtani T, Shimizu M, Takeda Y, Oka T, et al. Distal protection improved reperfusion and reduced left ventricular dysfunction in patients with acute myocardial infarction who had angioscopically defined ruptured plaque. Circulation. 2005; 112: 1001-7.
44. Ovize M, Baxter GF, Lisa FD, Ferdinandy P, Garcia-Dorado D, Hausenloy DJ, et al. Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc Res. doi: 10. 1093/cvr/cvq129.
45. Staat P, Rioufol G, Piot C, Cottin Y, Cung TT, L'Huillier I, et al. Postconditioning the human heart. Circulation. 2005; 112: 2143-8.
46. Lønborg PJ, Kelbæk H, Vejlstrup N, Jørgensen E, Helqvist S, Saunamäki K, et al. Cardioprotective effects of ischemic postconditioning in patients treated with primary percutaneous coronary intervention, evaluated by magnetic resonance. Circ Cardiovasc Interv. 2010; 3: 34-41.
47. Montalescot G, Barragan P, Wittenberg O, Ecollan P, Elhadad S, Villain P, et al. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med. 2001; 344: 1895-903.
48. Zijlstra F, de Boer MJ, Hoorntje JC, Reiffers S, Reiber JH, Suryapranata H. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med. 1993; 328: 680-4.
49. Marzilli M, Orsini E, Marraccini P, Testa R. Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction. Circulation. 2000; 101: 2154-9.
50. Ross AM, Gibbons RJ, Stone GW, Kloner RA, Alexander RW. A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II). J Am Coll Cardiol. 2005; 45: 1775-80.
51. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986; 74: 1124-36.
52. Li GC, Vasquez JA, Gallagher KP, Lucchesi BR. Myocardial protection with preconditioning. Circulation. 1990; 82: 609-19.
53. Ito H, Taniyama Y, Iwakura K, Nishikawa N, Masuyama T, Kuzuya T, et al. Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction. J Am Coll Cardiol. 1999; 33: 654-66.
54. Ishii H, Ichimiya S, Kanashiro M, Amano T, Imai K, Murohara T, et al. Impact of a single intravenous administration of nicorandil before reperfusion in patients with ST-segment-elevation myocardial infarction. Circulation. 2005; 112: 1284-8.
55. Taniyama Y, Ito H, Iwakura K, Masuyama T, Hori M, Takiuchi S, et al. Beneficial effect of intracoronary verapamil on microvascular and myocardial salvage in patients with acute myocardial infarction. J Am Coll Cardiol. 1997; 30: 1193-9.
56. Pasceri V, Pristipino C, Pelliccia F, Granatelli A, Speciale G, Roncella A, et al. Effects of the nitric oxide donor nitroprusside on no-reflow phenomenon during coronary interventions for acute myocardial infarction. Am J Cardiol. 2005; 95: 1358-61.
57. Théroux P, Chaitman BR, Danchin N, Erhardt L, Meinertz T, et al. Inhibition of the sodium-hydrogen exchanger with cariporide to prevent myocardial infarction in high-risk ischemic situations. Main results of the GUARDIAN trial. Circulation. 2000; 102: 3032-8.
58. Zeymer U, Suryapranata H, Monassier JP, Opolski G, Davies J, et al. The Na(+)/H(+) exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction. Results of the evaluation of the safety and cardioprotective effects of eniporide in acute myocardial infarction (ESCAMI) trial. J Am Coll Cardiol. 2001; 38: 1644-50.
59. Botker HE, Kharbanda R, Schmidt MR, Bøttcher M, Kaltoft AK, Terkelsen CJ, et al. Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. Lancet. 2010; 375: 727-34.